Skip to content

Stock-Based Comp at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$10.88M-5.6%
Viatris logo
ViatrisVTRS
$48.2M-12.7%
PTH
Pelthos Therapeutics Inc.PTHS
$1.91M+293%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3.46M+4.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3.11M-0.3%
Opko Health logo
Opko HealthOPK
$2.74M+4.5%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.4%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's stock-based comp?
Scilex Holding Company (SCLX) reported stock-based comp of $3.63M in Q1 2026.
How has Scilex Holding Company's stock-based comp changed year-over-year?
Scilex Holding Company's stock-based comp increased by 9.5% year-over-year, from $3.31M to $3.63M.
What is the long-term trend for Scilex Holding Company's stock-based comp?
Over 4 years (2021 to 2025), Scilex Holding Company's stock-based comp has grown at a 27.7% compound annual growth rate (CAGR), from $5.82M to $15.49M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.